首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   8938篇
  免费   542篇
  国内免费   436篇
耳鼻咽喉   2篇
儿科学   127篇
妇产科学   143篇
基础医学   382篇
口腔科学   22篇
临床医学   1517篇
内科学   1127篇
皮肤病学   41篇
神经病学   102篇
特种医学   173篇
外科学   3391篇
综合类   1119篇
预防医学   422篇
眼科学   30篇
药学   649篇
  8篇
中国医学   206篇
肿瘤学   455篇
  2024年   76篇
  2023年   179篇
  2022年   281篇
  2021年   429篇
  2020年   350篇
  2019年   291篇
  2018年   283篇
  2017年   289篇
  2016年   327篇
  2015年   416篇
  2014年   645篇
  2013年   665篇
  2012年   515篇
  2011年   472篇
  2010年   423篇
  2009年   397篇
  2008年   427篇
  2007年   436篇
  2006年   375篇
  2005年   383篇
  2004年   321篇
  2003年   248篇
  2002年   200篇
  2001年   208篇
  2000年   153篇
  1999年   118篇
  1998年   76篇
  1997年   76篇
  1996年   80篇
  1995年   106篇
  1994年   77篇
  1993年   72篇
  1992年   65篇
  1991年   44篇
  1990年   39篇
  1989年   44篇
  1988年   51篇
  1987年   26篇
  1986年   44篇
  1985年   44篇
  1984年   32篇
  1983年   19篇
  1982年   24篇
  1981年   15篇
  1980年   18篇
  1979年   15篇
  1978年   11篇
  1976年   7篇
  1975年   7篇
  1973年   4篇
排序方式: 共有9916条查询结果,搜索用时 31 毫秒
891.
R-94138, a matrix metalloproteinase inhibitor, was examined for the ability to prevent peritoneal dissemination of a human gastric cancer xenograft, TMK-1. When the supernatant of a co-culture of TMK-1 cells and human normal fibroblast cells was subjected to gelatin zymography, it was clear that the protein expression of MMP-2 had been inhibited by R-94138. When TMK-1 was injected intraperitoneally (i.p.) into nude mice at 5×105 cells/body, the resulting peritoneal dissemination mimicked clinical carcinomatous peritonitis. When the maximum tolerated dose of mitomycin C (MMC) or cisplatin (DDP) was given 12 h after the tumor inoculation, peritoneal dissemination was completely inhibited, while the effect of R-94138 was limited when it was given i.p. at a dose of 20 mg/kg in a schedule of q.d. ×5 starting 12 h after tumor injection. MMC and DDP also suppressed peritoneal dissemination when they were administered 1 week after the tumor inoculation at a single dose of 2 and 3 mg/kg i.p., respectively. R-94138 inhibited peritoneal dissemination when it was administered i.p. at a dose of 30 mg/kg in a schedule of q.d. ×5 starting from 1 week after tumor injection. The combination of MMC and R-94138 increased the preventive effect on peritoneal dissemination. R-94138 seems to be a promising candidate to prevent peritoneal dissemination of gastric cancer.  相似文献   
892.
人胃癌细胞腹膜粘附影响因素的实验研究   总被引:5,自引:1,他引:5  
Liu Q  Chen J 《中华肿瘤杂志》1999,21(5):336-338
目的 探讨影响人胃癌细胞在腹膜粘附的因素,为临床上采取有效措施,减少腹膜转移的发生提供依据。方法 用人胃癌细胞株在小鼠腹膜上培养,以MTT法检测粘附细胞数的体外实验模型,观察腹膜损伤,血液成分和癌胚抗原(CEA)对胃癌细胞在腹膜粘附的影响。结果 腹膜损伤组的粘附细胞数(AD)较对照组明显增高(P〈0.01),血液中的白细胞,血小板组AD值较对照组明显增高(P〈0.01),血浆组AD值亦较对照组增高  相似文献   
893.

Introduction

Peritoneal metastasis (PM) of hepatocellular carcinoma (HCC) without distant spread are rare. The related prognosis is poor without standard treatment available. The role of cytoreduction surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is poorly documented.

Methods

An international multicentric cohort was constituted by retrospective analysis of 21 patients undergoing CRS/HIPEC for PM of HCC between 1992 and 2016 from 10 reference centers of PSOGI. Data on clinical features, treatment strategies, and survival outcomes were analyzed.

Results

The median time interval from the diagnosis of PM to the procedure was 4.5 months. The median peritoneal cancer index was 14. Sixteen patients had complete cytoreduction (CCR0-1). Ten patients had grades 3 to 4 complications. The median duration of follow-up was 52.2 months. The median OS was 46.7 months. The projected 3y-OS and 5y-OS were 88.9 and 49.4% respectively. The median OS for patients with CCR0-1 resection was not reached whereas it was 5.9 months for those with CCR2-3 resection after CRS (p = 0.0005). The median RFS was 26.3 months and projected RFS at 3 years of 36.5 months Three prognostic factors were associated with improved RFS in the univariate analysis: preoperative chemotherapy (p = 0.0156), PCI >15 (p = 0.009), Number of chemotherapy agents used for HIPEC (p = 0.005).

Conclusion

CRS/HIPEC is a safe and effective approach in selected patients with PM of HCC. CRS/HIPEC gives the patient a chance for a good relapse free and overall survival and should be considered as an option.  相似文献   
894.

Background

Gastric Cancer (GC) with Peritoneal Carcinomatosis (PC) has long been regarded as a terminal disease. Over the past two decades, cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has changed the traditional concept of peritoneal metastases from being a systemic disease, to being considered a locoregional dissemination.

Patients and methods

A prospective study was performed at a high-volume Carcinomatosis Center to evaluate survival, morbi-mortality and prognostic factors for survival in a cohort of patients with GC and PC treated with CRS + HIPEC between June 2006 and December 2016.

Results

Thirty-five patients were included in the study. Median follow-up was 54 months. Postoperative major complications (>grade IIIa) occurred in 25.7% of patients, including 2 deaths (mortality 5.7%). The median overall survival (OS) was 16 months and the 1-, 3- and 5-year OS rates were 70.8%, 21.3% and 21.3% %, respectively. The median OS for patients with PCI ≤6 was 19 months, in contrast to 12 months for the 19 patients with PCI >6. Three patients were included with only a positive cytology and their median OS was not reached. Perineural invasion was the only factor that had a negative influence in prognosis (HR 18.8) in multivariate analysis.

Conclusion

Although GC with PC still has a poor prognosis, survival has improved in selected patients with CRS + HIPEC and perioperative systemic chemotherapy. Patients with isolated positive cytology or peritoneal carcinomatosis with PCI less than 6 had encouraging survival rates.  相似文献   
895.

Introduction

Patients with pT4 colon cancer are at risk of developing intra-abdominal recurrence. Infectious complications have shown to negatively influence disease free survival (DFS) and overall survival (OS) in stage I-III colon cancer. The aim of this study was to determine whether surgical site infections (SSIs) also increase the risk of intra-abdominal recurrence in pT4 colon cancer patients.

Methods

All consecutive patients with pT4N0-2M0 colon cancer from four centres between January 2000 and December 2014 were included. Patients were categorized into 2 groups; with and without a postoperative (<30 days) SSIs. SSIs included both deep incisional as well as organ/space SSIs. The primary outcome was intra-abdominal recurrence (including local/incisional recurrence, peritoneal metastases) and was assessed using Kaplan-Meier and Cox regression analyses. Secondary outcome measures were DFS and OS.

Results

Out of 420 patients, 62 (15%) developed a SSI. The 5-year intra-abdominal recurrence rates were 44% and 27% for patients with and without a SSI, respectively (p?=?0.011). After multivariate analysis, SSI was independently associated with intra-abdominal recurrence (HR 1.807 (1.091–2.992)), worse DFS (HR 1.788 (1.226–2.607)), and worse OS (HR 1.837 (1.135–2.973)). Other independent risk factors for intra-abdominal recurrence were a R1 resection (HR 2.616 (1.264–5.415)) and N2-stage (HR 2.096 (1.318–3.332)).

Conclusion

SSIs after resection of a pT4N0-2M0 colon cancer are associated with an increased risk of intra-abdominal recurrence and worse survival. This finding supports the hypothesis that infection-based immunologic pathways play a role in colon cancer cell dissemination and outgrowth.  相似文献   
896.
目的观察序贯透析对肾功能衰竭合并心力衰竭、肺水肿患者的治疗效果。方法对13例肾功能衰竭合并急性心力衰竭、肺水肿的患者行序贯透析疗法,观察其临床症状、体征,分析其疗效。结果痊愈7例,显效5例,有效1例,总有效率为100.0%。结论序贯透析能迅速缓解肾功能衰竭合并急性左心力衰竭患者的临床症状,改善患者的心功能状况,是抢救肾功能衰竭合并急性左心力衰竭的有效方法 。  相似文献   
897.
Scatophagus argus of the family Scatophagidae inflicts painful wounds in fishermen while handling it. The venom induces prominent local tissue damage characterized by pain, edema and necrosis. The pathogenesis of acute muscle damage in gastrocnemius muscle induced by S. argus venom was studied in mice. The inflammatory response induced by S. argus venom in the mice hind paw was studied measuring paw edema. Intramuscular injection of S. argus venom induced motoxicity. The effect of S. argus venom on the cellular components of inflammatory response was investigated. Venom from S. argus were quantitatively analyzed for enzymic and biochemical activity. The biochemical changes induced by the sublethal concentration of S. argus venom and histopathological studies of effect of venom on mice were carried out. Venom induced a rapid increment in serum creatine kinase (CK) and lactate dehydrogenase (LDH) showing the myotoxicity of venom. Concomitant with this a reduction of muscle CK and LDH activity was observed, where as no increment in muscle lactate was detected. Our findings showed that the edematic activity was dose dependent and remained significantly elevated over 48 h after injection. Administration of S. argus venom caused a significant cell accumulation of neutrophils in to peritoneal cavity as well as foot pad up to 24 h with maximal being at 4-6 h. The venom components analyzed showed the presence of phosphodiesterase, acid phosphatases, alkaline phosphatases, proteinase, and caseinolytic activity. SDS PAGE revealed the presence of major and minor protein bands between 6.5 and 68 kDa. The biochemical changes induced by the sublethal concentration of S. argus venom showed reversible changes in the hematological (blood cell count, hematocrit, hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin and platelet count) parameters which were significantly altered at 6 and 24 h (GLM repeated measures p < 0.05). Serum enzymes such as AST, ALT, ACP, ALP, LDH and urea were altered significantly which in turn confirmed the damage of vital organ tissue.  相似文献   
898.
目的研究腹膜透析短期内对高血压患者生化指标及免疫指标的影响。方法将48例2级高血压患者分为2组:腹膜透析组(CAPD组)和对照组。对照组不进行腹膜透析。连续6个月后观察。结果 CAPD组和高血压组的血清白蛋白、内皮素、血肾素以及血管紧张素Ⅱ治疗前无统计学差异,治疗后有统计学差异。两组的血红蛋白、血清K+、血清Na+于治疗前后并无差异。结论对于有腹膜透析需要的高血压患者,可以在短期内治疗基础病的同时降低高血压相关的生理、生化以及免疫指标。  相似文献   
899.
目的探讨分析胆道术后腹腔引流液中炎性因子检测对胆漏的早期诊断价值。方法将160例胆道术后24h、48h、72h的腹腔引流液分别进行CRP、TNF-α、IL-6的检测,同时对不同原因引起的胆漏患者,进行腹腔引流液检测,对结果进行分析总结。结果 160例胆道手术的患者,术后出现胆漏13例,占8.13%,未出现胆漏147例,占91.87%。13例不同胆漏患者进行术后3次腹腔引流液中炎性因子检测平均结果:CRP(33.76±1.28)mg/L、TNF-α(45.83±2.37)ng/L、IL-6(33.68±4.51)ng/L。胆道患者手术后腹腔引流液中炎性因子均会引起不同程度的升高,而胆漏组患者的腹腔引流液中炎性因子明显高于未出现胆漏的患者。结论胆道术后腹腔引流液炎性因子检测CRP、TNF-α、IL-6早期异常升高,可以作为对早期胆漏的诊断参考依据。  相似文献   
900.
目的: 通过检测胃癌腹腔冲洗液中DDC mRNA的表达,探讨多巴胶羟酶(DDC)与胃癌腹膜转移的关系,并为胃癌腹膜转移预测和亚临床转移的筛检提供新的方法。 方法: 用RNA提取和RT-PCR方法检测92例胃癌腹腔冲洗液中DDC mRNA的表达,同时做腹腔冲洗细胞学(PLC)检查;10例良性疾病的腹腔冲洗液作为阴性对照。 结果: 92例胃癌腹腔冲洗液中有57例检测到DDC mRNA的表达(62.0%),其表达阳性率与胃癌腹膜转移的PS因素密切相关(P<0.05);且胃癌腹腔冲洗液中DDC mRNA的表达水平还与胃癌浸润深度、浆膜类型、PLC检查结果以及是否存在肉眼腹膜转移有关,浸润深度深、浆膜受侵程度重、PLC检查结果阳性及存在肉眼腹膜转移病灶者的DDC mRNA表达相对值明显升高(P<0.05);而10例良性疾病腹腔冲洗液均未检测到DDC mRNA的表达。 结论: 胃癌腹腔液中DDC mRNA的表达与胃癌腹膜转移密切相关,通过RT-PCR来检测DDC mRNA适用于胃癌腹膜转移的预测和亚临床转移的筛检。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号